Ozempic® 0.5mg (Japanese Version) – Semaglutide Injection for Type 2 Diabetes & Weight Loss

Key Features

• Active Ingredient: Semaglutide (GLP-1 receptor agonist)

• Dosage: 0.5 mg, administered once a week

• Administration: Subcutaneous injection in the abdomen, thigh, or upper arm

• Weight Management: Supports gradual and sustainable weight loss

• Blood Sugar Control: Lowers blood glucose and HbA1c levels

• Cardiovascular Protection: Reduces risk of heart attack, stroke, and cardiovascular death in high-risk patients

Description

Ozempic® 0.5mg (Japanese version) is an advanced injectable medication designed to improve glycemic control in adults with type 2 diabetes. Powered by semaglutide, it works by stimulating insulin secretion, reducing glucagon levels, and slowing gastric emptying.

In addition to blood sugar management, Ozempic® has been clinically proven to promote weight loss and protect against major cardiovascular events in patients with existing heart disease.

Ingredients

• Semaglutide – active ingredient

• Dibasic sodium phosphate dihydrate – stabilizer

• Phenol – preservative

• Propylene glycol – solvent

• Water for injections – solvent

How to Use

• Starting Dose: 0.25 mg once weekly for the first 4 weeks

• Increase to: 0.5 mg after 4 weeks

• Administration Sites: Abdomen, thigh, or upper arm – rotate sites to prevent irritation

• Missed Dose: Take within 5 days; otherwise, skip and continue with the regular schedule

• Can be injected with or without food, at any time of day

Extra Info

• Common Side Effects: Nausea, vomiting, diarrhea, abdominal discomfort, decreased appetite

• Serious Side Effects: Pancreatitis, thyroid tumors (including MTC), kidney injury

• Storage: Refrigerate between 2–8°C before first use; after first use, store at room temperature for up to 6 weeks

What’s in the Box

• 1 pre-filled pen containing Ozempic® 0.5 mg (Japanese packaging)

• Pen needles (may vary by distributor)

• Patient information leaflet and instructions

Why Choose

Ozempic® 0.5mg is trusted worldwide for its dual benefits – controlling blood sugar and supporting weight loss – with proven cardiovascular protection. Manufactured by Novo Nordisk, a global leader in diabetes care, it offers a convenient once-weekly regimen with lasting results.

For patients focusing primarily on weight reduction without diabetes treatment, you may also consider Saxenda® (Liraglutide) Weight Loss Injection, another GLP-1 based therapy.